CLEC9A and neoplasm: Our integrated analysis of publication trends, clinical trial data, and research frontiers highlights the critical role of DNGR-1 in tumor immunotherapy and cDC1 functional regulation, providing theoretical and empirical insights for developing novel immunotherapies targeting the DNGR-1-cDC1 axis.